NCI Launches Prostate Cancer Prevention Trial
The National Cancer Institute today launched a 12-year, $180 million study to determine whether two dietary nutrients can prevent prostate cancer.
The Selenium and Vitamin E Cancer Prevention Trial, or SELECT, is one of the largest-ever prostate-cancer prevention studies ever undertaken, involving 32,400 men in the United States, Canada and Puerto Rico.
SELECT is the first study designed to look specifically at the effects of vitamin E and selenium, both separately and together, in preventing prostate cancer.
The Selenium and Vitamin E Cancer Prevention Trial, or SELECT, is one of the largest-ever prostate-cancer prevention studies ever undertaken, involving 32,400 men in the United States, Canada and Puerto Rico.
SELECT is the first study designed to look specifically at the effects of vitamin E and selenium, both separately and together, in preventing prostate cancer.
